We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Antigenics Inc. announced that the company has signed expanded license and supply agreements for the use of QS-21 Stimulon adjuvant
with GlaxoSmithKline Biologicals, a vaccine division of GlaxoSmithKline (GSK).
Athenagen, Inc. and Zapaq, Inc., both privately held biopharmaceutical companies, said that they have signed a letter of intent to merge the two companies.
Takeda Pharmaceutical Company Limited ("Takeda") and Galaxy Biotech, LLC ("Galaxy") announced that on July 1, both parties have entered into an agreement for the development and
marketing of HuL2G7, a humanized anti-Hepatocyte Growth Factor (HGF) monoclonal antibody created by Galaxy.
Biogen Idec's controversial multiple sclerosis (MS) drug Tysabri will now be available in Europe for serious cases of the disease, the company announced.
The activist group that filed a lawsuit claiming political pressure from the White House and others forced the FDA to delay approving OTC sale of a controversial contraceptive is now urging the president to order the agency to approve the drug.
Officials said Thursday that JRS Pharma plans a $15 million plant expansion this fall next to its sister company, Germany-based J. Rettenmaier, in southeastern Cedar Rapids.